EPIQ Series Diagnostic Ultrasound System vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
EPIQ Series Diagnostic Ultrasound System
by Philips
VS
Tempus ECG-Low EF
by Tempus

AI Verdict

Tool A is a comprehensive AI-powered ultrasound system offering advanced imaging and workflow solutions across diverse clinical applications, including cardiology. Tool B is a specialized AI software designed to analyze ECG recordings specifically for the detection of low left ventricular ejection fraction, aiding in heart failure risk identification. While both leverage AI in cardiology, Tool A provides broad diagnostic imaging capabilities, whereas Tool B offers a targeted ECG-based risk assessment.

Choose EPIQ Series Diagnostic Ultrasound System if…

Choose the Philips EPIQ Series Diagnostic Ultrasound System if your facility requires a premium, multi-specialty imaging solution for comprehensive, real-time diagnostic evaluation. This system excels in providing high-definition, AI-enhanced images and advanced measurements across cardiology, OB/GYN, and radiology, enabling detailed anatomical and functional assessments. It is ideal for situations demanding precise visualization and advanced diagnostic confidence for a wide range of conditions.

View EPIQ Series Diagnostic Ultrasound System →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your clinical workflow needs an efficient, AI-powered screening tool to identify patients at risk of low left ventricular ejection fraction from standard 12-lead ECGs. This software provides a quick binary output, helping clinicians prioritize patients aged 40 or older for further diagnostic evaluation for heart failure. It is best suited for early risk stratification within existing ECG analysis processes to prompt subsequent, more definitive diagnostic steps.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EPIQ Series Diagnostic Ultrasound System Tempus ECG-Low EF
Deployment Unknown Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Unknown Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EPIQ Series Diagnostic Ultrasound System Tempus ECG-Low EF
Name EPIQ Series Diagnostic Ultrasound System Tempus ECG-Low EF
Company Philips Ultrasound Tempus AI
Description The Philips EPIQ Series Diagnostic Ultrasound System offers premium AI-powered imaging and advanced workflow solutions for enhanced diagnostic confidence across diverse clinical applications. Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation.
Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI
Key Features nSIGHT Imaging Architecture, PureWave Crystal Technology, xMATRIX Transducer Technology, Anatomical Intelligence Ultrasound (AIUS), AI-Enhanced Imaging & Automated Measurements, Elastography (Shear Wave & Strain), SmartExam & Real Time iSCAN (Autoscan), Flow Viewer & MicroFlow Imaging High Definition (MFI HD) AI-powered algorithm for ECG analysis, Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%), Analyzes resting, non-ambulatory 12-lead ECG recordings, Provides a binary output (Low LVEF Detected / Not Detected), Aids in identifying patients 40+ years at risk of heart failure, Trained on a large dataset of over 930,000 ECGs from 170,000+ patients, Intended for use in clinical diagnostic settings at healthcare facilities

Videos

Demos, reviews, and walkthroughs featuring EPIQ Series Diagnostic Ultrasound System and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the Philips EPIQ Series Diagnostic Ultrasound System, is a premium AI-powered imaging system designed for diverse clinical applications, providing detailed anatomical and functional insights through ultrasound imaging. Tool B, Tempus ECG-Low EF, is an AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure.
The Philips EPIQ Series utilizes AI for enhanced imaging, automated measurements, and smarter workflows across various ultrasound applications, aiming to improve diagnostic confidence and efficiency. Tempus ECG-Low EF employs an AI-powered algorithm specifically for ECG analysis to identify a single, targeted condition: signs of low LVEF.
The Philips EPIQ Series is designed for a broad range of specialties including Cardiology, OB/GYN, Radiology, Emergency Medicine, Orthopedics, Pediatrics, and Urology. Tempus ECG-Low EF is primarily intended for Cardiology, Emergency Medicine, and Internal Medicine, focusing on identifying patients at risk of heart failure.
The Philips EPIQ Series provides comprehensive diagnostic images, advanced measurements, and intelligent insights across various anatomical structures and clinical applications. Tempus ECG-Low EF delivers a binary output, indicating either 'Low LVEF Detected' or 'Not Detected,' to aid clinicians in further evaluation for low LVEF.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring EPIQ Series Diagnostic Ultrasound System or Tempus ECG-Low EF

Backers

Who funded each tool's parent company.

Tempus ECG-Low EF

AI Tool Finder
AI-powered search. Results may not be comprehensive.